Does BAMLANIVIMAB Cause Hyperglycaemia? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hyperglycaemia have been filed in association with BAMLANIVIMAB. This represents 0.3% of all adverse event reports for BAMLANIVIMAB.
16
Reports of Hyperglycaemia with BAMLANIVIMAB
0.3%
of all BAMLANIVIMAB reports
1
Deaths
16
Hospitalizations
How Dangerous Is Hyperglycaemia From BAMLANIVIMAB?
Of the 16 reports, 1 (6.3%) resulted in death, 16 (100.0%) required hospitalization.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BAMLANIVIMAB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does BAMLANIVIMAB Cause?
Dyspnoea (833)
Infusion related reaction (663)
Pyrexia (641)
Chills (453)
Oxygen saturation decreased (448)
Nausea (422)
Covid-19 (346)
Cough (342)
Covid-19 pneumonia (313)
Hypoxia (310)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which BAMLANIVIMAB Alternatives Have Lower Hyperglycaemia Risk?
BAMLANIVIMAB vs BAMLANIVIMAB\ETESEVIMAB
BAMLANIVIMAB vs BARACLUDE
BAMLANIVIMAB vs BARICITINIB
BAMLANIVIMAB vs BARIUM
BAMLANIVIMAB vs BARNIDIPINE